Jay Edelberg

Direktor/Vorstandsmitglied bei Prolaio, Inc.

Health Technology

Commercial Services

Consumer Services

Aktive Positionen von Jay Edelberg

Unternehmen	Position	Beginn	Ende
Prolaio, Inc. Prolaio, Inc. BiotechnologyHealth Technology Prolaio, Inc. is a company founded in 2021 that engages in research and development of medical. The company is based in Scottsdale, AZ.	Direktor/Vorstandsmitglied	-	-
	Unternehmenssekretär	-	-

Unternehmen	Position	Beginn	Ende
MYOKARDIA, INC.	Technik-/Wissenschafts-/F&E-Leiter	-	01.11.2020
SANOFI	Corporate Officer/Principal	-	-

Duke University

Doctorate Degree

International

Vereinigte Staaten	4
Frankreich	2

Operativ

Corporate Officer/Principal	1
Chief Tech/Sci/R&D Officer	1
Doctorate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
SANOFI	Commercial Services

Private Unternehmen	2
MyoKardia, Inc. MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA.	Health Technology
Prolaio, Inc. Prolaio, Inc. BiotechnologyHealth Technology Prolaio, Inc. is a company founded in 2021 that engages in research and development of medical. The company is based in Scottsdale, AZ.	Health Technology

Private Unternehmen

Health Technology